JSJingjing Song

Jingjing Song

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Jingjing Song has a total of 53 co-authors. Here are the top co-authors by number of shared publications:

  • Jiansong Ji

    Department of Radiology, Lishui Hospital of Zhejiang University, Lishui, China

    5 shared publications
  • Jianfei Tu

    Ningbo University

    3 shared publications
  • Minjiang Chen

    Department of Pulmonary and Critical Care Medicine Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China

    3 shared publications
  • Zhongwei Zhao

    Medical College, Yanbian University, Yanji, People’s Republic of China

    3 shared publications
  • Chenying Lu

    Key Laboratory of Imaging Diagnosis and Minimally Invasive Intervention Research, The Fifth Affiliated Hospital of Wenzhou Medical University, Affiliated Lishui Hospital of Zhejiang University, The Central Hospital of Zhejiang Lishui, Lishui, 323000, China; Department of Radiology, The Fifth Affiliated Hospital of Wenzhou Medical University, Affiliated Lishui Hospital of Zhejiang University, The Central Hospital of Zhejiang Lishui, Lishui, 323000, China

    2 shared publications
  • Fazong Wu

    Department of radiology, Lishui Hospital of Zhejiang University, School of Medicine, Lishui 323000, China

    2 shared publications

Latest Publications

  • Monodisperse CaCO3-loaded gelatin microspheres for reversing lactic acid-induced chemotherapy resistance during TACE treatment

    by Minjiang Chen, Xiaoju Guo, Lin Shen, Jiayi Ding, Junchao Yu, Xiaoxiao Chen, Fazong Wu, Jianfei Tu, Zhongwei Zhao, Mitsutoshi Nakajima, et al.


  • Single-cell transcriptome analysis reveals tumor immune microenvironment heterogenicity and granulocytes enrichment in colorectal cancer liver metastases

    by Yunbin Zhang, Jingjing Song, Zhongwei Zhao, Mengxuan Yang, Ming Chen, Chenglong Liu, Jiansong Ji, Di Zhu


  • Piplartine suppresses proliferation and invasion of hepatocellular carcinoma by LINC01391-modulated Wnt/β-catenin pathway inactivation through ICAT

    by Xiaoxi Fan, Jingjing Song, Zhongwei Zhao, Minjiang Chen, Jianfei Tu, Chenying Lu, Fazong Wu, Dengke Zhang, Qiaoyou Weng, Liyun Zheng, et al.


  • Short‐term efficacy, safety, and cost‐effectiveness of transarterial chemoembolization with drug‐eluting beads versus synchronous radiochemotherapy for cervical cancer

    by Jingjing Song, Weiqian Chen, Xiaohua Zhu, Zhongwei Zhao, Minjiang Chen, Lingcong Huang, Jianfei Tu, Hongyou Zhou, Lihong Zhou, Jiansong Ji

    Objective: To investigate the short‐term efficacy and safety of transarterial chemoembolization with drug‐eluting beads (DEB‐TACE) versus synchronous radiochemotherapy among women with cervical cancer.Methods: A retrospective cohort study of women treated by synchronous radiochemotherapy (n=20) and DEB‐TACE (n=20) at a single center in China between November 2015 and September 2017. Inclusion criteria were pathologic diagnosis of cervical cancer, age at least 18 years, and complete clinicopathologic information. Hospital stay, direct medical cost, resection frequency, adverse events, treatment responses, progression‐free survival (PFS) and overall survival (OS) were compared between treatments.Results: There was no difference in treatment responses, PFS, or OS between the two groups. Hospital stay was shorter, direct medical costs were lower, and resection rate was higher in the DEB‐TACE group than in the radiochemotherapy group (all P<0.05). In univariate and multivariate logistic regression analysis, no factor was associated with complete response. No predictive factor for PFS or OS was identified by Cox proportional regression analysis. Fewer adverse advents were recorded in the DEB‐TACE group than in the synchronous radiochemotherapy group.Conclusion: Among women with cervical cancer, DEB‐TACE achieved equal short‐term efficacy, better tolerance, less hospital stay and medical costs, and higher resection rates as compared with synchronous radiochemotherapy.


  • Non–Small-Cell Lung Cancer: Feasibility of Intratumoral Radiofrequency Hyperthermia–enhanced Herpes Simplex Virus Thymidine Kinase Gene Therapy

    by Jiansong Ji, Qiaoyou Weng, Feng Zhang, Fu Xiong, Yin Jin, Junguo Hui, Jingjing Song, Jun Gao, Minjiang Chen, Qiang Li, et al.

    Radiofrequency hyperthermia-enhanced gene therapy may introduce a paradigm for effective management of unresectable lung cancer by integrating the advantages of interventional molecular imaging with direct intratumoral gene therapy. Purpose To validate the feasibility and efficacy of intratumoral radiofrequency hyperthermia (RFH)-enhanced herpes simplex virus (HSV) thymidine kinase (TK) and ganciclovir (GCV) (hereafter, HSV-TK/GCV) gene therapy for non–small-cell lung cancer (NSCLC). Materials and Methods This study was performed from November 11, 2015, to April 14, 2017, and included (a) in vitro experiments with human NSCLC cells to establish the proof of principle, (b) in vivo experiments using mice with subcutaneous NSCLC to further demonstrate the principle, and (c) in vivo experiments using rats with orthotopic NSCLC to validate the technical feasibility. Cells, nude mice, and nude rats were randomly divided into four groups (six animals per group): (a) combination therapy (HSV-TK/GCV combined with RFH), (b) RFH, (c) HSV-TK/GCV, and (d) phosphate-buffered saline. Data were analyzed by using the Dunnett t test or Kruskal–Wallis test. Results For in vitro experiments, the cell proliferation assay showed significantly diminished v...


  • Open Access

    Do Future Limitation Perspective in Cancer Patients Predict Fear of Cancer Recurrence, Mental Distress, and the Ventromedial Prefrontal Cortex Activity?

    by Jia Zhou, Pan Feng, Xiaofei Lu, Xingping Han, Yanli Yang, Jingjing Song, Guangyu Jiang, Yong Zheng

    Life-threatening diseases (e.g., cancer) affect people’s future time perspective (FTP) and affect their mental health. When one’s lifetime is perceived as running out, the individual possesses a future limitation perspective (FLP), which is one of factors in FTP. In this study, we explored the structural relationship between FLP, fear of cancer recurrence (FCR), mental health status (MHS), and brain activity in patients with cancer. Cancer patients were divided into two groups using the FTP scale and Feelings About Life Scale: a strong FLP group (S-FLP) and a weak FLP group (W-FLP). For these groups, we measured cancer patients’ MHS using the Symptom Checklist (SCL-90) and FCR using the Cancer Acceptance Scale; brain activity was measured using resting-state functional magnetic resonance imaging (rs-fMRI). Behavioral results showed that the S-FLP group had higher mental symptoms and FCR scores than did the W-FLP group. Neuroimaging results revealed that spontaneous brain activity in the ventromedial prefrontal cortex (vmPFC) was stronger in the W-FLP group than in the S-FLP group. Moreover, brain activity in the vmPFC negatively correlated with FLP, FCR, and SCL-90 scores only in the S-FLP group, and the model constructed further indicated that FCR and SCL-90 scores fully mediated the relationship between FLP and vmPFC activities. These findings suggested that a strong FLP might lead to mental disorders and greater FCR, which might change the spontaneous activity of the vmPFC in cancer patients.


  • Open Access

    SMAD7 loci contribute to risk of hepatocellular carcinoma and clinicopathologic development among Chinese Han population

    by Jiansong Ji, Min Xu, Zhongwei Zhao, Jianfei Tu, Jun Gao, Chenying Lu, Jingjing Song, Weiqian Chen, Minjiang Chen, Xiaoxi Fan, et al.

    // <![CDATA[ $('.header-date').hide();$('#titleAuthors').hide();$('#abstractHeader').hide(); // ]]> Jiansong Ji1, *, Min Xu1, *, Zhongwei Zhao1, *, Jianfei Tu1, *, Jun Gao2, *, Chenying Lu1, Jingjing Song1, Weiqian Chen1, Minjiang Chen1, Xiaoxi Fan1, Xingyao Cheng1, Xilin Lan1, Jie Li3 1Department of Radiology, The Fifth Affiliated Hospital of Wenzhou Medical University/Affiliated Lishui Hospital of Zhejiang University/The Central Hospital of Zhejiang Lishui, Lishui, Zhejiang, P.R. China 2Department of Hepatobiliary Surgery, Beijing Chao-yang Hospital Affiliated with Capital Medical University, Beijing, P.R. China 3The First Affiliated Hospital, Chongqing Medical University, Chongqing, P.R. China *These authors contributed equally to this work Correspondence to: Jiansong Ji, e-mail: jijiansongzjls@163.com Keywords: HCC, mothers against decapentaplegic homolog 7 (SMAD7), transforming growth factor beta (TGF-β), risk, SNP Received: November 05, 2015 Accepted: February 05, 2016 Published: March 14, 2016 ABSTRACT Genome-wide association studies (GWAS) have identified three loci at 18q21 (rs4939827, rs7240004, and rs7229639), which maps to SMAD7 loci, were associated with risk of diseases of the digestive system. However, their associations with hepatocellular carcinoma (HCC) risk remain unknown. A case-control study was conducted to assess genetic associations with HCC risk and clinicopathologic development among Chinese Han population. Three SNPs were genotyped among 1,000 HCC cases and 1,000 controls using Sequenom Mass-ARRAY technology. We observed statistically significant associations for the three SMAD7 loci and HCC risk. Each copy of minor allele was associated with a 1.24–1.36 fold increased risk of HCC. We also found that significant differences were observed between rs4939827 and clinical TNM stage and vascular invasion, as well as rs7240004 and vascular invasion. We also established a genetic risk score (GRS) by summing the risk alleles. The GRS was significantly associated with increased risk of HCC and vascular invasion. Our data revealed the SMAD7 loci is associated with HCC susceptibility and its clinicopathologic development.